Innate Pharma S.A.

EPA:IPH.PA

1.616 (EUR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Operating Activities:
Net Income -7.57-58.103-52.809-63.984-20.7593.049-48.38512.64-6.706-19.647-2.892-3.199-6.98-13.658-14.626-9.852-8.918-6.042-6.129
Depreciation & Amortization 5.09145.4054.59656.79716.5297.4014.3933.2632.6552.3440.880.8390.9011.11.0230.5390.5360.2980.301
Deferred Income Tax 00-1.6822.653-4.1441.1553.171-2.614-0.586-0.078-0.00900-0.2591.06000.0491.635
Stock Based Compensation 4.2564.2492.6172.4753.8262.7079.8291.0311.0110.3770.32500.2190.0351.7741.3441.261.1870.214
Change In Working Capital -32.091-12.502-9.884-49.20440.246-47.096-16.98-50.788211.491-1.3-9.415-8.55919.12-0.6666.778-7.629-2.2714.867-1.635
Accounts Receivables 0-4.2043.394-22.919110.296-130.710.978-16.174-6.141-2.0740.379-2.0120000000
Inventory 00-6.27225.382000000000000000
Accounts Payables -3.893-7.662-0.946-6.5281.38534.3354.3887.8899.2351.657-5.5210.9690000000
Other Working Capital -28.198-0.636-6.06-45.13938.861-47.096-16.98-58.677202.256-0.883-4.273-7.5160000000
Other Non Cash Items -2.2441.797-1.295-0.544-0.7740.253-0.088-0.3830.0470.170.1440.444-0.274-0.001-1.9450.8570.1110.001-1.635
Operating Cash Flow -32.558-19.154-58.457-51.80734.924-32.531-48.06-36.851207.912-18.134-10.967-10.47512.986-13.449-5.936-14.741-9.2820.36-7.249
Investing Activities:
Investments In Property Plant And Equipment -2.354-1.122-1.33-11.282-65.401-1.429-6.026-9.393-7.397-2.343-0.433-1.225-0.322-0.408-0.511-1.902-1.296-0.752-0.112
Acquisitions Net 000.0070.00900.0223.0628.0430-0.06-0.1200000.375000
Purchases Of Investments 0.00100-300-43.272-18.154-121.867-1.963-2.996-2.03200-0.549-15.9130-99.449-5.359
Sales Maturities Of Investments 22.76830-0.009225.66219.83888.0576.9670.5412.47602.76702041.465.96661.2094.041
Other Investing Activites 0.216-0.0010.4060.9121.280.046-3.062-8.0430.9720.0020.115-0.15400.1190-1.4990.30400
Investing Cash Flow 20.6311.877-0.917-13.37-62.12124.279-29.4660.51-122.297-3.823-0.958-3.4112.445-0.28918.9422.5214.974-38.992-1.43
Financing Activities:
Debt Repayment -2.361-2.02626.631-0.88511.918-1.3430.537-0.685-0.452-0.6130.314-2.264-0.719-0.789-0.2570.6230.3390.7120.249
Common Stock Issued 0.3950.1980.4990.04966.00662.5570.4910.0140.12547.78519.0850.1160.0240.00823.11700.29341.4930
Common Stock Repurchased 000000000-0.07000-0.112-0.30000
Dividends Paid 000000000-0.850000-1.20000
Other Financing Activities 0.39500.188-0.251-0.1590.0080.3780.0693.3591.6980.27800.03601.1990-0.0010.0010
Financing Cash Flow -1.966-1.82826.818-1.13677.76561.2220.915-0.6023.03247.9519.677-2.148-0.659-0.89322.5590.6230.63142.2060.249
Other Information:
Effect Of Forex Changes On Cash 0.274-0.428-0.4830.2190.005-0.0260.066-0.023-0.063-0.0680.0230.0120.0170.00100000
Net Change In Cash -13.62-19.531-33.036-66.09550.57352.947-76.53923.03688.58425.9267.776-16.02214.788-14.6335.5638.403-3.6773.574-8.43
Cash At End Of Period 70.60584.225103.756136.792202.887152.31499.367175.906152.8764.28638.3630.58446.60631.81846.44810.8852.4826.1592.585